Recorded Chinese product: 注射用奥扎格雷钠注射用奥扎格雷钠
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 长春远大国奥制药有限公司Chinese legal name: 长春远大国奥制药有限公司
主要成分Active Ingredients
- 奥扎格雷钠Aozha Gelei Na
药物知识说明
奥扎格雷钠是一种在国家药监局注册认定的药品。该药品含有奥扎格雷钠-0e89edc9等成分。
该药品关联的活性成分包括：奥扎格雷钠Aozha Gelei Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：长春远大国奥制药有限公司Chinese legal name: 长春远大国奥制药有限公司。
您可以探索含有相同成分的其他药品：奥扎格雷钠-0e89edc9成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用奥扎格雷钠) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 奥扎格雷钠Aozha Gelei Na.
Manufacturers recorded for this product: 长春远大国奥制药有限公司Chinese legal name: 长春远大国奥制药有限公司.
Explore other medicines containing the same ingredient: 奥扎格雷钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用奥扎格雷钠Recorded Chinese product: 注射用奥扎格雷钠
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 20mg(按C13H11N2O2Na计)Recorded Chinese specification: 20mg(按C13H11N2O2Na计)
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 长春远大国奥制药有限公司Chinese legal name: 长春远大国奥制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20044704
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20044704
Manufacturer
Chinese legal name: 长春远大国奥制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20044704
生产企业
长春远大国奥制药有限公司(国产)
适应症
本品适用于治疗急性血栓性脑梗死和脑梗死所伴随的运动障碍。
用法用量
成人一次40mg～80mg(2～4支)，一天1～2次，溶于500ml生理盐水或5%葡萄糖溶液中，连续静脉滴注，2周为一疗程。
不良反应
1.胃肠道反应和过敏反应，如恶心、呕吐、荨麻疹、皮疹等，经适当处理后得到缓解。|2.少数可出现GPT?BUN升高，颅内、消化道、皮下出血及血小板减少等。
禁忌
1.出血性脑梗塞，或大面积脑梗塞深度昏迷者。|2.有严重心、肺、肝、肾功能不全，如严重心律不齐、心肌梗塞者。|3.有血液病或有出血倾向者。|4.严重高血压，收缩压超过26.6kpa以上(即200毫米汞柱以上)。.. 对本品过敏者。
注意事项
1.本品与抑制血小板功能的药物并用有协同作用，必须适当减量。|2.本品避免与含钙输液（格林氏溶液等）混合使用，以免出现白色混浊。
贮藏
遮光，密闭保存。
规格
20mg(按C13H11N2O2Na计)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.